Obese children and adolescents with hyperinsulinemia and/or impaired fasting glucose or impaired glucose tolerance who took metformin daily for six months attained significant reductions in BMI compared with those in the placebo group, a study found. Improvements in fasting glucose, alanine aminotransferase and adiponectin-to-leptin ratio were also seen in metformin-treated patients, researchers noted. The findings appear in the Journal of Clinical Endocrinology & Metabolism.
Obese children, teens on metformin show reduced BMI
SmartBrief Job Listings for Health Care
|Clinical Trials Agreements Specialist (209955)||
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
|Catheter Engineer Manager||
ASAHI INTECC, Orange County CA R&D Center
|Santa Ana, CA|
|Neurovascular Intervention Product Sales Rep, North East||
|Multiple Locations, SL_Multiple Locations|
|Senior Manager, Compliance||
|Director, Office of Device Evaluation||
FDA, Center for Devices and Radiological Health
|Silver Spring, MD|